How big is the complex generics market | Size, Trends & Forecast to 2025

Q: What is the current size of the complex generics market?

The complex generics market was valued at USD 70.0 billion in 2024 and is projected to reach USD 160.0 billion by 2031.

Q: What is the growth rate of the complex generics market?

The market is anticipated to grow at a CAGR of 10.2% between 2025 and 2031.

Q: Which product categories contribute the most to the complex generics market?

Injectables, inhalable, ophthalmic, transdermal patches, and modified-release drugs are major contributors.

Q: What is driving demand in the complex generics market?

The demand is fueled by biologic patent expirations, cost efficiency, supportive regulations, and global healthcare access initiatives.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA5649

Publication Date: Jul 2025

How big is the Complex Generics Market?

According to 6Wresearch internal database and industry insights, thecomplex generics market was valued at approximatelyUSD 70.0 billion in 2024 and is projected to reachUSD 160.0 billion by 2031, growing at aCAGR of 10.2% during the forecast period.

The market is expanding steadily, supported by biologic patent expirations, rising demand for specialty medicines, and the need for cost-effective complex drug alternatives.

Key Growth Drivers of the Complex Generics Market

Expiring patents of biologics and specialty drugs
Rising demand for cost-effective complex therapies
Growth in contract manufacturing and outsourcing
Regulatory support for complex generic approvals
Technological advancements in drug delivery formats

Complex Generics Market Trends

The Complex Generics Market is witnessing increased focus on injectable, inhalable, and ophthalmic drug formats that replicate complex branded therapies. Manufacturers are investing in advanced bioequivalence studies and scalable production technologies to meet regulatory standards and reduce development timelines. Integration of AI in formulation design and quality control is also accelerating innovation and compliance. Strategic collaborations with global pharma and CDMOs are improving market access, product pipelines, and technical capabilities. Additionally, companies are incorporating real-time data analytics and predictive modeling to streamline development processes and reduce regulatory rejection rates.

Emerging Developments in the Complex Generics Market

The Complex Generics Market is seeing developments in nanoparticle-based delivery systems, transdermal patches, and complex injectables targeting chronic diseases. Companies are prioritizing sustainable manufacturing, litigation preparedness, and multi-market approvals for faster entry. Firms are expanding capabilities in controlled-release formulations and drug-device combinations to differentiate offerings and increase therapeutic value. Pipeline advancements in oncology, respiratory, and CNS segments are also shaping the competitive landscape.